Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

To The East! Leo CEO On Astellas Deal And Global Ambitions

This article was originally published in PharmAsia News

Executive Summary

The acquisition of Astellas's dermatology business for €675m ($725m) by Denmark's skin disease specialist Leo Pharma, announced Nov. 11, is as much about satisfying the company's desire to reach critical mass in certain markets, including China, as it is about reviving an aging portfolio of products.

Advertisement

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register